All lobbying filings

INFUSION PROVIDERS ALLIANCE

INFUSION PROVIDERS ALLIANCE filed a Q3 report for INFUSION PROVIDERS ALLIANCE on October 19, 2026.

Lobbying for INFUSION PROVIDERS ALLIANCE

All filings by INFUSION PROVIDERS ALLIANCE · Everything INFUSION PROVIDERS ALLIANCE has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 19, 2026

Expenses

$110,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Medicare/Medicaid

Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act

Health Issues

Advocating for access to and reimbursement for biosimilars. Issues related to vertical integration and white bagging. Issues related to patient access to products for asthma and allergies.

Bills named in this filing 1

H.R. 4299
Protecting Patient Access to Cancer and Complex Therapies Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.